Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 1096 AL 1110

Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients

Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, Baumgartner R, Attems J, Gerner C, Jellinger K, Roth E, Oehler R, Umlauf E.

J Proteomics. 2012 Apr 3;75(7):2080-92. doi: 10.1016/j.jprot.2012.01.014. Epub 2012 Jan 17.

Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease

Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Scheper W.

Neurodegener Dis. 2012;10(1-4):212-5. doi: 10.1159/000334536. Epub 2012 Feb 1.

Effects of natural antioxidants in neurodegenerative disease

Albarracin SL, Stab B, Casas Z, Sutachan JJ, Samudio I, Gonzalez J, Gonzalo L, Capani F, Morales L, Barreto GE.

Nutr Neurosci. 2012 Jan;15(1):1-9. doi: 10.1179/1476830511Y.0000000028.

Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders

Cai H, Cong WN, Ji S, Rothman S, Maudsley S, Martin B.

Curr Alzheimer Res. 2012 Jan;9(1):5-17. doi: 10.2174/156720512799015064.

Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease

Xu Y, Yan J, Zhou P, Li J, Gao H, Xia Y, Wang Q.

Prog Neurobiol. 2012 Apr;97(1):1-13. doi: 10.1016/j.pneurobio.2012.02.002. Epub 2012 Feb 25.

The effect of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis

Rahayel S, Frasnelli J, Joubert S.

Behav Brain Res. 2012 May 16;231(1):60-74. doi: 10.1016/j.bbr.2012.02.047. Epub 2012 Mar 5.

Catechol-o-methyltransferase and Alzheimer's disease: a review of biological and genetic findings

Serretti A, Olgiati P.

CNS Neurol Disord Drug Targets. 2012 May;11(3):299-305. doi: 10.2174/187152712800672472.

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications

Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando SB, Aasly JO, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N.

Mol Neurodegener. 2012 Apr 11;7:13. doi: 10.1186/1750-1326-7-13.

NADPH oxidases: novel therapeutic targets for neurodegenerative diseases

Gao HM, Zhou H, Hong JS.

Trends Pharmacol Sci. 2012 Jun;33(6):295-303. doi: 10.1016/j.tips.2012.03.008. Epub 2012 Apr 11.

Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature

Wojtera M, Sobów T, Kłoszewska I, Liberski PP, Brown DR, Sikorska B.

Folia Neuropathol. 2012;50(1):74-84.

Sleep disturbances in Alzheimer's and Parkinson's diseases

Rothman SM, Mattson MP.

Neuromolecular Med. 2012 Sep;14(3):194-204. doi: 10.1007/s12017-012-8181-2. Epub 2012 May 3.

The pharmacological properties and therapeutic use of apomorphine

Ribarič S.

Molecules. 2012 May 7;17(5):5289-309. doi: 10.3390/molecules17055289.

Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease

Wang LS, Leung YY, Chang SK, Leight S, Knapik-Czajka M, Baek Y, Shaw LM, Lee VM, Trojanowski JQ, Clark CM.

J Alzheimers Dis. 2012;31(2):439-45. doi: 10.3233/JAD-2012-120082.

Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase

Priyadarshini M, Kamal MA, Greig NH, Reale M, Abuzenadah AM, Chaudhary AG, Damanhouri GA.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):482-9. doi: 10.2174/187152712800792767.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias